Skip to main content
. 1996 Jan;11(1):58–68. doi: 10.3904/kjim.1996.11.1.58

Table 2.

Comparative Results of Hepatocellular Carcinoma between α-IFN Plus Cis-platinum Treated Group (n=30) and Non-antitumor Therapy Group (n=26)

IFN- α plus cis-platinum group Control group
Complete Response 0(0.0%) 0(0.0%)
Partial Response 4(13.3%) 0(0.0%)
Stable disease 15(50.0%) 5(19.2%)
Progressive disease 11(36.7%) 21(80.8%)

Total 30(100%) 26(100.0%)